Diagnostic Lab Agreement

This Agreement is made on [Date] at [Place] between [Platform Legal Name] ("Platform") and [Laboratory Legal Name], a laboratory registered under the applicable Clinical Establishments law and holding NABL accreditation No. [●] ("Laboratory").

1. SCOPE

1.1  The Platform shall list the Laboratory's diagnostic and pathology test offerings, enabling Users to book sample collection (home or in-lab) and receive reports, subject to the terms herein.

2. INDEPENDENT CONTRACTOR STATUS

2.1  The Laboratory is an independent contractor. The Platform does not perform, supervise or interpret any diagnostic test and has no control over the Laboratory's testing methodology, equipment, or reporting.

2.2  The contract for testing services is directly between the User and the Laboratory. The Platform is not a party to it.

3. ACCREDITATION AND QUALITY WARRANTY

3.1  The Laboratory warrants continuing NABL accreditation (or equivalent), registration under applicable Clinical Establishments law, and compliance with the Clinical Establishments (Central Government) Rules quality standards applicable to diagnostic centres, and shall promptly notify the Platform of any change in accreditation status.

3.2  The Laboratory is solely responsible for the accuracy, calibration, chain-of-custody, and timely delivery of test reports. The Platform's role is limited to booking facilitation and report-delivery routing, and the Platform does not review, verify or interpret any test result.

4. SAMPLE COLLECTION AND HOME VISITS

4.1  Where home sample collection is offered, the Laboratory shall ensure its phlebotomists/collection staff are trained, background-verified, and follow standard biosafety and cold-chain protocols. The Laboratory is solely liable for any injury, contamination, or mishandling occurring during collection or transport.

5. TURNAROUND TIME AND SLA

5.1  The Laboratory shall report results within the turnaround time represented on the Platform listing for each test. Repeated failure to meet represented turnaround times shall entitle the Platform to suspend the listing.

6. DATA PROTECTION

6.1  Test results and health data routed through the Platform shall be processed by the Laboratory solely for the purpose of delivering the test result to the User, in compliance with the Digital Personal Data Protection Act, 2023, and shall not be used for any secondary purpose (including marketing) without separate consent.

7. FEES

7.1  The Platform shall be entitled to a facilitation fee of [●]% of the test value per booking, or a flat listing/technology fee, as set out in Schedule A, invoiced and settled in accordance with applicable GST/TDS law.

8. INDEMNITY

8.1  The Laboratory shall indemnify the Platform against all claims, losses and liabilities arising from: (a) inaccurate, delayed, or mishandled test reports; (b) negligence during sample collection; (c) breach of NABL/regulatory standards; and (d) any data protection violation attributable to the Laboratory.

8.2  The Platform's liability, if any, is limited to booking/dispatch facilitation failures attributable to the Platform's own systems, and excludes any liability for report accuracy or clinical interpretation.

9. INSURANCE

9.1  The Laboratory shall maintain professional indemnity insurance of not less than INR [●] and furnish proof annually.

10. TERM, TERMINATION, DISPUTE RESOLUTION AND GENERAL

10.1  This Agreement shall run for [●] year(s) from the date hereof, terminable by either Party on [30] days' notice, or immediately by the Platform upon loss of accreditation or credible complaints of report inaccuracy or malpractice.

10.2  Disputes shall be resolved by arbitration under the Arbitration and Conciliation Act, 1996, seated at [City]; courts at [City] retain jurisdiction for interim relief. This Agreement is governed by the laws of India.

SCHEDULE A — FEES

[To be populated: fee structure, invoicing cycle, settlement timeline]

IN WITNESS WHEREOF

the Parties have executed this Agreement through their authorised representatives on the date first written above.